[경제]Some securities companies’ access failure due to the surge in SK Bioscience’s transaction…”Damage compensation”

[경제]Some securities companies’ access failure due to the surge in SK Bioscience’s transaction…”Damage compensation”

by

[앵커]

This morning, on the second day of SK Bioscience’s listing, the trading demand of stock investors surged, and there was a problem with access to the trading system of some securities companies, such as Mirae Asset Daewoo.

As a result, investors suffered great inconvenience, and Mirae Asset Daewoo said it would reasonably compensate for any damages.

Reporter Lee Jong-soo on the report.

[기자]

Mirae Asset Daewoo’s home trading system and mobile trading system experienced a connection error right after the opening of the domestic stock market.

It recovered after about an hour and 40 minutes, and there were calls to investors asking for a solution to the problem.

[김계현 / 피해자 : 9시 경에 장 시작과 맞춰서 로그인을 하려 했는데 로그인이 안되고 계속 화면 로딩 중 화면이 계속 나오면서 더 이상 진행이 안되더라고요. 그게 1시간 가까이 그런 증상이 반복됐었어요. 결국은 1시간 동안 주식을 매도, 매수를 못하고 속만 졸이고 있는 상태였죠.]

Mirae Asset Daewoo said it would compensate for the damage, saying it was due to the surge in SK Bioscience stock trading.

[미래에셋대우 관계자 : SK바이오사이언스 주식을 거래하려는 고객들이 일시적으로 급증해서 일부 MTS나 HTS 접속오류가 발생했습니다. 향후 피해가 있는 고객의 경우 관련 규정에 근거해서 합리적으로 보상을 제공하도록 할 예정입니다.]

NH Investment & Securities also experienced delays in contract inquiry due to the surge in SK Bioscience transactions.

Accordingly, NH Investment & Securities announced, “Please confirm the settlement through stock balance/profit or loss or account balance.”

In the case of Korea Investment & Securities, some users experienced delays in access from the network or terminal, but it was confirmed that there was no problem with the company’s server.

In addition, Toss Securities also experienced some connection failures or delays in the morning.

As SK Biosciences has many minority shareholders who received one week each in the process of applying for public offerings, the industry understands that the number of individual access is much higher than that of other stocks.

SK Bioscience, which recorded a double upper limit on the date of listing, closed the transaction at 166,000 won, which was given by 2,500 won, down 1.48% from the previous day’s closing price.

YTN Jongsoo Lee[[email protected]]is.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

.Source